All posts by: Michael Zand

About Michael Zand

Immunotherapy Approaches against Chronic Form of Leukemia Emerge – Genetic Engineering & Biotechnology News

Continue reading

2017-07-31 NEWS

Immunotherapy Approaches against Chronic Form of Leukemia Emerge
Genetic Engineering & Biotechnology News
Y RNA is a reason why monocytes and macrophages assist, rather than assault, the cancer cells that proliferate in chronic lymphocytic leukemia (CLL). Not much is known about Y RNA, but one particular Y RNA, hy4, has been found in great abundance in the …

Continue reading

2017-07-31 NEWS

Immunotherapy Approaches against Chronic Form of Leukemia Emerge
Genetic Engineering & Biotechnology News
Y RNA is a reason why monocytes and macrophages assist, rather than assault, the cancer cells that proliferate in chronic lymphocytic leukemia (CLL). Not much is known about Y RNA, but one particular Y RNA, hy4, has been found in great abundance in the …

Continue reading

2017-07-31 NEWS

Stem Cell Therapy can provide a surgery-free solution to knee and shoulder issues
Colorado Springs Gazette
There was a time when stem cell therapy was out of reach for most people, but it has become increasingly accessible in recent years; and a go-to solution for a range of physiological complications. “Stem cells are blank cells in the body that can

Continue reading

2017-07-31 NEWS

Medgadget (blog)

Global Stem Cell Market – Positive long term growth outlook 2016-21
Medgadget (blog)
According to the report “Global Stem Cell Market,” published by Market Data Forecast, the global market is projected to reach USD 30.19 billion by 2021 from USD 15.82 billion in 2016, at a CAGR of 13.8% from 2016 to 2021. Stem cell therapy, also known
US Regenerative Medicine Market to Grow at a CAGR of 23.53% to 2021satPRnews (press release)

all 2 news articles »